Novavax, Inc. (NVAX) - Wutah bathi ing taun lumaku

NVAX (novavax.com) - tandha merek perusahaan

The 12-month earnings per share growth rates correlate with the optimization of global vaccine distribution, where site diversification mitigates risks. The value of -101.60 defines the current metric, while strategic platform licensing ensures capital inflows. The financial results of Novavax, Inc. (NVAX) rely on the sale of innovative influenza and coronavirus drugs developed using recombinant nanoparticles.

NVAX Wutah bathi saben saham ing taun lumaku Novavax Pharma (04.07.2022 - 15.11.2026)

Rincian metrik komprehensif lan analitis Novavax (NVAX)

- rega saham lan target rega konsensus:
Bagan owah-owahan rega Novavax, Inc.|NVAX - Target konsensus
- indikator kapitalisasi pasar:
Kapitalisasi pasar Novavax, Inc.|NVAX - Nilai Total Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Saham Novavax|NVAX - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku novavax.com|NVAX - Aset Agregat Perusahaan
- rincian utang lan likuiditas:
Utang marang Modal Novavax, Inc.|NVAX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Novavax|NVAX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Novavax Inc|NVAX - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Novavax|Rasio cepet novavax.com
- data bathi lan kelipatan valuasi:
NVAX - Penghasilan resik|Prakiraan bathi resik Novavax, Inc.|NVAX - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Novavax, Inc.|NVAX - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Novavax, Inc.|NVAX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone 12 wulan pungkasan Novavax|NVAX - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan novavax.com|NVAX - Wutah bathi resik saben saham ing taun iki|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Novavax, Inc.
- data pendapatan lan penerimaan dodolan:
NVAX - Pendapatan perusahaan|Prakiraan pendapatan perusahaan Novavax, Inc.|NVAX - Kapitalisasi marang pendapatan|Rasio rega marang prakiraan pendapatan Novavax|NVAX - Wutah dodolan YoY (TTM)
Pambiji fundamental:Novavax, Inc.
Produk mawa merek novavax.com

The ability of Novavax, Inc. (NVAX) to commercialize new vaccines amidst fierce competition determines the long-term viability of the business. By analyzing the year-over-year change in EPS, an investor can track the dynamics of net income per share, which allows for an assessment of cost management efficiency and the pace of profitability recovery following the pandemic slump to determine the asset's fair value.

Pesaing wigati

Gilead Sciences, Inc. - Tambahing bathi saben saham ing taun lumaku|Wutah bathi resik saben saham ing taun iki CDTX|Wutah bathi ing taun lumaku curevac.com|Wutah bathi saben saham ing taun lumaku Valneva Corp (VALN)|Wutah bathi saben saham ing taun lumaku VIR (Vir Biotechnology)|Wutah bathi saben saham ing taun lumaku TPOXX SIGA|EBS - Wutah bathi resik saben saham ing taun iki|AVIR: Wutah bathi resik saben saham ing taun iki|IVVD (Invivyd Inc) - Wutah bathi saben saham ing taun iki|ENTA: Wutah bathi ing taun lumaku|INO (Inovio) - Wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku HilleVax Corp|Wutah bathi ing taun lumaku Kalaris Tx|Wutah bathi ing taun lumaku DYAI|Wutah bathi saben saham ing taun lumaku NNVC (NanoViricides)|Wutah bathi ing taun lumaku TLPH (Talphera Corporation)|Prakiraan wutah bathi resik saben saham ing taun iki Cocrystal (COCP)|TRAW - Wutah bathi saben saham ing taun lumaku|DWTX (Dogwood Therapeutics Inc.) - Wutah bathi saben saham ing taun iki|Qualigen Therapeutics, Inc. (QLGN) - Wutah bathi saben saham ing taun lumaku|AlloVir Inc - Tambahing bathi saben saham ing taun lumaku|VBIV (VBI Vaccines) - Wutah bathi ing taun lumaku|VIRI: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku VXRT